Chetan Kantilal Kanabar

Insider activity · 24 months1 buy1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 1 buy · 1 saleFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 23 Jan 2026 for JB Chemicals & Pharmaceuticals Limited, €147k.

Filing timeline

BuySale

Chetan Kantilal Kanabar

Chetan Kantilal Kanabar: trading record in brief

All filings by Chetan Kantilal Kanabar on record concern JB Chemicals & Pharmaceuticals Limited. Over a trading history stretching from 21 January 2026 to 23 January 2026, the count stands at 4 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 23 January 2026, reports a transaction of €147k in JB Chemicals & Pharmaceuticals Limited. Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.